Singapore – September 07, 2026 -- Haier Biomedical (SHA: 688139) reported that revenue from pharmaceutical clients rose 23% year-on-year in the first half of 2026, while laboratory solutions revenue grew 19%, as the company unveiled new automated bio-storage and connected pharmaceutical technologies at the ISPE Singapore Conference & Exhibition 2026.
Automated -80°C storage system makes international exhibition debut
Held August 20-21 at Suntec Singapore, the event served as the venue for the first international showing of Haier Biomedical's automated ultra-low-temperature storage solution. The system combines automated -80°C storage with intelligent sample management to improve workflow efficiency and traceability for pharmaceutical companies and research organizations handling high-value samples.
Pilot freeze dryer links lab research to manufacturing stages
The company also presented a pilot-scale freeze dryer designed to support pharmaceutical process development and support teams connecting laboratory research with downstream manufacturing. The two products address complementary needs across sample management, process development and pilot-scale production.
RFID-enabled ULT storage links physical samples to digital records
During a Power Hour session, Haier Biomedical detailed its RFID-enabled intelligent ULT storage solution, which assigns unique identities to each sample via RFID tags while compartment antennas and readers capture data without visual scanning. The software links each sample to its location and movement history, generating structured entry and exit records. The configurable system supports bottles, bags, tubes and cryovials through customizable racks, trays and holders, and is built to reduce manual searching and inventory reconciliation while strengthening chain-of-custody visibility across quality control, storage and supply chain operations.
AI-related business reaches 18% of revenue, up 3 points
Haier Biomedical's exhibition portfolio also included automation systems, ULT freezers, refrigerated centrifuges and freeze-thaw systems supporting workflows from R&D and production to QC labs and cold storage. In the first half of 2026, AI-related business accounted for 18% of total revenue, a 3-percentage-point increase from 2025, as the company shifts from standalone equipment sales toward multi-product portfolios, scenario-specific solutions and ongoing services.
The company said it is adapting products and technologies to local regulations, infrastructure and customer needs across global markets.